How to Cite
Abstract
Psoriasis is a chronic immune disorder that develops after exposure to a skin lesion; either traumatic, medicinal or infectious in genetically predisposed people. It presents in a classic way as erythematous confluent plaques, micaceous scales with well-defined borders, however there are other clinical cutaneous forms. Beyond skin involvement, psoriasis is also associated with a number of important medical and psychiatric comorbidities, including psoriatic arthritis, cardiovascular disease, diabetes, malignancies, depression, and anxiety. Its treatment depends on the severity of the clinical picture, ranging from topical preparations to systemic treatments, without forgetting the multidisciplinary management of its comorbidities.
Keywords
References
Christopher E M Griffiths, April W Armstrong, Johann E Gudjonsson, Jonathan N W N Barker. Psoriasis. Lancet 2021. 397: 1301–15
Dr Stephen J Mounsey, Dr Elizabeth
Kulakov. Psoriasis. British Journal of Hospital Medicine, August 2018, Vol 79, No 8
Frank O. Nestle, M.D., Daniel H. Kaplan, M.D., Ph.D., and Jonathan Barker, M.D. Mechanisms of Disease: Psoriasis. The New England Journal of Medicine, 2009;361:496-509.
Tokuyama, M., & Mabuchi, T. (2020). New Treatment Addressing the Pathogenesis of Psoriasis. International Journal of Molecular Sciences, 21(20), 7488. https://doi.org/10.3390/ijms21207488
AprilW. Armstrong, MD, MPH; Charlotte Read, MBBS, BSc. JAMA May 19, 2020 Volume 323, Number 19. https://doi.org/10.1001/jama.2020.4006
Luigi Naldi, MD, Daniele Gambini, MD. The clinical spectrum of psoriasis. Clinics in Dermatology, Volume 25, Issue 6, 2007. https://doi.org/10.1016/j.clindermatol.2007.08.003
Todke, P. and Shah, V.H. (2018), Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches. Int J Dermatol, 57: 1387-1402. https://doi.org/10.1111/ijd.14047
Dra. Natacha López Pupo, Dra. María Elena Tablada Robinet, Dra. Ana Lucía Jacas Portuondo, Dra. Adelina Baltazar Green, Dr. Luis Felipe González Vázquez. Factores de riesgo y comorbilidades en pacientes con psoriasis. MEDISAN 2019;23(3):436
Young, M., Aldredge, L. and Parker, P. (2017), Psoriasis for the primary care practitioner. Journal of the American Association of Nurse Practitioners, 29: 157-178. https://doi.org/10.1002/2327-6924.12443
Erica B. Lee, BS; Kevin K. Wu, BA; Michael P. Lee, BS; Tina Bhutani, MD; Jashin J. Wu, MD (2018) Psoriasis Risk Factors and Triggers. Cutis. VOL. 102 NO. 5S
Stephen M. Schleicher,Psoriasis: Pathogenesis, Assessment, and Therapeutic Update (2016). Clinics in Podiatric Medicine and Surgery,Volume 33, Issue 3 http://dx.doi.org/10.1016/j.cpm.2016.02.004
Karl T. Clebak, MD, FAAFP; Leesha Helm, MD, MPH; Matthew F. Helm, MD; Elizabeth V. Seiverling, MD (2020).The many variants of psoriasis. THE JOURNAL OF FAMILY PRACTICE, VOL 69, NO 4
Alisa Brandon, Asfandyar Mufti, R. Gary Sibbald (2019) Diagnosis and Management of Cutaneous Psoriasis: A Review. Advances in Skin and Wound Care, VOL. 32 NO. 2
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019). Risk Factors for the Development of Psoriasis. International Journal of Molecular Sciences, 20(18), 4347. https://doi.org/10.3390/ijms20184347
Lionel Fry, Barbara S. Baker, Triggering psoriasis: the role of infections and medications, Clinics in Dermatology, Volume 25, Issue 6, 2007, Pages 606-615, ISSN 0738-081X.
Kluger, N., Estève, E., Fouéré, S., Dupuis-Fourdan, F., Jegou, M.-H. and Lévy-Rameau, C. (2017), Tattooing and psoriasis: a case series and review of the literature. Int J Dermatol, 56: 822-827. https://doi.org/10.1111/ijd.13646
Elena Pezzolo & Luigi Naldi (2018): The relationship between smoking, psoriasis and psoriatic arthritis, Expert Review of Clinical Immunology, https://doi.org/1080/1744666X.2019.1543591
Whan B. Kim MD Dana Jerome MD MEd FRCPC Jensen Yeung (2017). Diagnosis and management of psoriasis. Canadian Family Physician. VOL 63: APRIL
Barboza Hernández, W. M., & Sobrado Es¬quivel, F. L. Psoriasis: : Revisión bibliográ-fica. Revista Ciencia Y Salud, 5(3), Pág. 52–59. https://doi.org/10.34192/cien-ciaysalud.v5i3.305
I. Belinchón, L. Salgado-Boquete, A. López-Ferrer, M. Ferran, P. Coto-Segura, R. Rivera, D. Vidal, L. Rodríguez, P. de la Cueva, R. Queiro, El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos, Actas Dermo-Sifiliográficas, Volume 111, Issue 10, 2020, Pages 835-846, https://doi.org/10.1016/j.ad.2020.06.004
Shivani P. Reddy,Kathryn Martires,Jashin J. Wu (2017), The risk of melanoma and hematologic cancers in patients with psoriasis, Journal of the American Academy of Dermatology, VOLUME 76, NUMBER 4, http://dx.doi.org/10.1016/j.jaad.2016.09.047
Llamas-Velasco M, et al. Psoriasis moderada. Propuesta de definición. Actas Dermosifiliogr. 2017. http://dx.doi.org/10.1016/j.ad.2017.07.002
Pi Zhang, P., Wu, M.X. A clinical review of phototherapy for psoriasis. Lasers Med Sci 33, 173–180 (2018). https://doi.org/10.1007/s10103-017-2360-1
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Kamata, M., & Tada, Y. (2020). Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review. International Journal of Molecular Sciences, 21(5), 1690. https://doi.org/10.3390/ijms21051690
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Array